Market Place
Sourcing Support
Ardena’s Nanomedicine Facility Secures Full GMP Approval
18 Nov 2024 //
PRESS RELEASE
Ardena Expands Bioanalytical Services in Europe
29 Oct 2024 //
GLOBENEWSWIRE
Catalent to sell New Jersey facility
15 Oct 2024 //
REUTERS
Ardena Expands US Footprint With Acquisition Of Catalent Facility
14 Oct 2024 //
PRESS RELEASE
Ardena Announces Leadership Changes For Growth And Expansion
16 Jul 2024 //
PRESS RELEASE
Ardena announces key leadership changes to drive growth and international expansion
16 Jul 2024 //
PRESS RELEASE
Ardena appoints Jeremie Trochu as Chief Executive Officer
06 Jun 2024 //
PR NEWSWIRE
Ardena Receives GMP Approval for New Analytical Labs in Expanded Facility
18 Apr 2024 //
CONTRACT PHARMA
Ardena Bolsters US Business Development with Key Appointment in the East Coast
09 Jan 2024 //
PRESS RELEASE
Race Inks Agreement with Ardena for GMP Manufacturing of RC220
12 Jul 2023 //
CONTRACT PHARMA
Ardena Appoints Christian Renken as Business Development Director West Coast
06 Apr 2023 //
PRESS RELEASE
Celebrating a milestone of our new Nanomedicines facility
14 Mar 2023 //
PRESS RELEASE
Ardena Joins EUCOPE, the European Confederation of Pharmaceutical Entrepreneurs
02 Feb 2023 //
PRESS RELEASE
Ardena Announces Major Expansion of Swedish Facility
26 Oct 2022 //
CONTRACTPHARMA
Ardena confirms spray drying upgrade and other capabilities at Spanish site
11 May 2022 //
PHARMAFILE
Ardena Acquires Idifarma from Suanfarma and Sodena
02 Sep 2021 //
CONTRACTPHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.